11.1 Information on toxicological effects
Acute toxicity
LD50 Oral - Rat - female - 550 mg/kg (OECD Test Guideline 425)
LC50 Inhalation - Rat - male and female - 4 h - 5,2 mg/l - aerosol (OECD Test Guideline 403)
Dermal: No data available
Skin corrosion/irritation
Skin - Rabbit
Result: No skin irritation - 4 h (OECD Test Guideline 404)
Serious eye damage/eye irritation
Eyes - Rabbit
Result: Causes serious eye damage. - 24 h (OECD Test Guideline 405)
Respiratory or skin sensitization
Local lymph node assay (LLNA) - Mouse
Result: Causes sensitization.
(OECD Test Guideline 429)
Remarks: No data available
Germ cell mutagenicity
Classified based on available data. For more details, see section 2
Test Type: Chromosome aberration test in vitro
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 473
Result: negative
Test Type: Ames test
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: negative
Carcinogenicity
Classified based on available data. For more details, see section 2
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
Endocrine disrupting properties
Product:
Assessment : The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.
The following applies to lithium compounds in general: when handled or used inappropriately, the absorption of large quantities is followed by CNS disorders, agitation, spasms, ataxia (impaired locomotor coordination) due to disturbed electrolyte balance.
The following applies to oxalates in general: nausea and vomiting after swallowing.
Mucosal irritations, coughing, and dyspnoea after inhalation. Systemic effect: drop in the blood calcium level, toxic effect on kidneys, cardiovascular disorders.
The following applies to boron compounds in general: resorption is followed by nausea and vomiting, agitation, spasms, CNS disorders, cardiovascular disorders.
Further data:
Other dangerous properties can not be excluded.
Handle in accordance with good industrial hygiene and safety practice.